Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Saha

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Clinical and Vaccine Immunology : CVI|September 11, 2009
Salmonella enterica serovar Typhi-specific immunoglobulin A antibody responses in plasma and antibody in lymphocyte supernatant specimens in Bangladeshi patients with suspected typhoid feverAlaullah Sheikh, M Saruar Bhuiyan, Farhana Khanam, et al.
The Journal of Infectious Diseases|July 20, 2005
Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in BangladeshFirdausi Qadri, Mohiul I Chowdhury, Shah M Faruque, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 10, 2017
Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejectionPeter J Kennel, Amit Saha, Dawn A Maldonado, et al.
BMC Infectious Diseases|May 17, 2019
Safety of a bivalent, killed, whole-cell oral cholera vaccine in pregnant women in Bangladesh: evidence from a randomized placebo-controlled trialAshraful Islam Khan, Mohammad Ali, Julia Lynch, et al.
Clinical and Vaccine Immunology : CVI|March 24, 2012
Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in BangladeshDaniel T Leung, Mohammad Arif Rahman, M Mohasin, et al.
Plos Neglected Tropical Diseases|May 3, 2014
Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in HaitiRichelle C Charles, Isabelle J Hilaire, Leslie M Mayo-Smith, et al.
The American Journal of Cardiology|April 7, 2024
Characteristics of High-Performing Hospitals in Cardiogenic Shock Following Acute Myocardial InfarctionAmit Saha, Shuang Li, James A de Lemos, et al.
Sexually Transmitted Infections|June 23, 2026
Impact of decentralised, community-led molecular STI point-of-care testing on testing practices in remote First Nations communities in AustraliaAnnie Tangey, Kirsty Smith, Belinda Hengel, et al.
Clinical and Vaccine Immunology : CVI|June 29, 2012
Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired choleraMohammad Arifuzzaman, Rasheduzzaman Rashu, Daniel T Leung, et al.
The Lancet Regional Health. Western Pacific|July 2, 2024
Clinical effectiveness and analytical quality of a national point-of-care testing network for sexually transmitted infections integrated into rural and remote primary care clinics in Australia, 2016-2022: an observational program evaluationLouise M Causer, James Ward, Kirsty Smith, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Clinical and Vaccine Immunology : CVI|September 11, 2009
Salmonella enterica serovar Typhi-specific immunoglobulin A antibody responses in plasma and antibody in lymphocyte supernatant specimens in Bangladeshi patients with suspected typhoid feverAlaullah Sheikh, M Saruar Bhuiyan, Farhana Khanam, et al.
The Journal of Infectious Diseases|July 20, 2005
Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in BangladeshFirdausi Qadri, Mohiul I Chowdhury, Shah M Faruque, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 10, 2017
Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejectionPeter J Kennel, Amit Saha, Dawn A Maldonado, et al.
BMC Infectious Diseases|May 17, 2019
Safety of a bivalent, killed, whole-cell oral cholera vaccine in pregnant women in Bangladesh: evidence from a randomized placebo-controlled trialAshraful Islam Khan, Mohammad Ali, Julia Lynch, et al.
Clinical and Vaccine Immunology : CVI|March 24, 2012
Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in BangladeshDaniel T Leung, Mohammad Arif Rahman, M Mohasin, et al.
Plos Neglected Tropical Diseases|May 3, 2014
Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in HaitiRichelle C Charles, Isabelle J Hilaire, Leslie M Mayo-Smith, et al.
The American Journal of Cardiology|April 7, 2024
Characteristics of High-Performing Hospitals in Cardiogenic Shock Following Acute Myocardial InfarctionAmit Saha, Shuang Li, James A de Lemos, et al.
Sexually Transmitted Infections|June 23, 2026
Impact of decentralised, community-led molecular STI point-of-care testing on testing practices in remote First Nations communities in AustraliaAnnie Tangey, Kirsty Smith, Belinda Hengel, et al.
Clinical and Vaccine Immunology : CVI|June 29, 2012
Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired choleraMohammad Arifuzzaman, Rasheduzzaman Rashu, Daniel T Leung, et al.
The Lancet Regional Health. Western Pacific|July 2, 2024
Clinical effectiveness and analytical quality of a national point-of-care testing network for sexually transmitted infections integrated into rural and remote primary care clinics in Australia, 2016-2022: an observational program evaluationLouise M Causer, James Ward, Kirsty Smith, et al.
Pageof 12